CD34 and acute myeloid leukemia: Moreover, most cases of de novo CD34+ AML originate from phenotypically identifiable HPC, including MLP and/or GMP, which acquire abnormal self-renewal potential; this suggests that CD34+ AML is a progenitor cell disease (18).